Post by Giancarlo Francese
Strategic Pharma Executive | Board Member | Health Innovation & Capital Allocation Strategy | From Science to Scalable Platforms
Africa imports roughly 70–80% of its medicines. That single number tells you almost everything about why supply shocks, stock-outs, and last-mile gaps remain the continent's hardest health-systems problem. The logistics challenge behind it is real: supply chains are fragmented across 54 markets, regulatory pathways diverge, and last-mile distribution remains the binding constraint on access. Building local manufacturing without integrated regional logistics simply moves the bottleneck. This week in Geneva, on the margins of the 79th World Health Assembly, a roadmap was launched to position Morocco as a continental hub for pharmaceutical production, health logistics, and regional distribution — anchored in the World Bank's AIM2030 initiative. The ambition is straightforward: an Africa-for-Africa model where the continent produces, distributes, and supplies its own health products at scale. This initiative reflects months of work with an exceptional team on its design and operational architecture — bringing together manufacturing capacity, integrated cold chain, regulatory convergence, and resilient supply corridors as one system, not four. It takes a collective effort across institutions and partners, and Morocco's geography, industrial base, and reform momentum make it the right anchor for that execution. https://lnkd.in/eAfgJ7mC #GlobalHealth #HealthEquity #PharmaceuticalManufacturing #SupplyChain #AIM2030 #AfricaForAfrica #Morocco #HealthAccess #ImpactInvesting #PrivateEquity #BlendedFinance #DevelopmentFinance #Logistics #LocalManufacturing